Usc Norris Comprehensive Cancer Center is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Usc Norris Comprehensive Cancer Center has participated in 9 clinical trials with 7 currently active.
Therapeutic areas: Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation, Anemia, Post-essential Thrombocythemia Myelofibrosis.
Sponsors: Institut de Recherches Internationales Servier, Incyte Corporation, Genmab.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Usc Norris Comprehensive Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Usc Norris Comprehensive Cancer Center has 9 clinical trials on record, with 7 currently active. Their work covers Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation, Anemia, Post-essential Thrombocythemia Myelofibrosis.
Yes — Usc Norris Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.